---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-017648"
form_type: "8-K"
ticker: "CRVO"
cik: "0001053691"
company_name: "CervoMed Inc."
filed_at: "2024-05-20T23:59:59+00:00"
generated_at: "2026-06-01T12:09:27.974864+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CervoMed names William Elder as CFO; William Tanner departs to consulting role

## Summary
- William Elder appointed CFO effective June 1, 2024, succeeding William Tanner; Elder continues as General Counsel and Corporate Secretary.
- Outgoing CFO William Tanner to serve as consultant through Dec 2025; receives $162,000 severance plus prorated bonus and extended stock option vesting.
- Elder's compensation: base salary $429,000, target bonus 35% of base; severance includes 9 months salary on non-cause termination.
- Company expects RewinD-LB Phase 2b enrollment completion in Q2 2024, topline efficacy results in Q4 2024.

## SEC filing metadata
- accession: 0001437749-24-017648
- form_type: 8-K
- ticker: CRVO
- cik: 0001053691
- company_name: CervoMed Inc.
- filed_at: 2024-05-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.02, 1.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053691/000143774924017648/0001437749-24-017648-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053691/000143774924017648/crvo20240520_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-017648
- JSON: https://secwatch.observer/filing/0001437749-24-017648.json
- Plain text: https://secwatch.observer/filing/0001437749-24-017648.txt

## Key facts
- Executive change
  William Elder was appointed as Chief Financial Officer at CervoMed Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: appointed William Elder, the Company’s current General Counsel, Corporate Secretary and Acting Principal Financial Officer, to serve as the Company’s Chief Financial Officer, effective June 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1053691/000143774924017648/0001437749-24-017648-index.htm
- Executive change
  William Tanner was terminated as Chief Financial Officer at CervoMed Inc..
  - Action: terminated
  - Role: Chief Financial Officer
  source text: Dr. Tanner’s employment with the Company will terminate effective May 31, 2024, and, effective June 1, 2024, Dr. Tanner will begin service as a consultant to the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1053691/000143774924017648/0001437749-24-017648-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.